🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Revive Therapeutics Ltd. (CSE:RVV)
Canada flag Canada · Delayed Price · Currency is CAD
0.0100
0.00 (0.00%)
Nov 20, 2026, 3:43 PM EST

Revive Therapeutics Income Statement

Millions CAD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Selling, General & Admin
0.821.382.041.942.68
Research & Development
-0.141.113.5815.16
Operating Expenses
1.071.653.295.5317.84
Operating Income
-1.07-1.65-3.29-5.53-17.84
Interest Expense
--0-0.02-0.04-0.06
Interest & Investment Income
000.060.110.12
Currency Exchange Gain (Loss)
-0.04-0.05---
EBT Excluding Unusual Items
-1.1-1.7-3.25-5.46-17.78
Gain (Loss) on Sale of Investments
-0-0.01-0.05-0.09-
Asset Writedown
--9.38-2.34-0.78-
Other Unusual Items
0.080.070.02--0.03
Pretax Income
-1.02-11.01-5.62-6.32-17.81
Net Income
-1.02-11.01-5.62-6.32-17.81
Net Income to Common
-1.02-11.01-5.62-6.32-17.81
Net Income Growth
-----
Shares Outstanding (Basic)
434420380339320
Shares Outstanding (Diluted)
434420380339320
Shares Change
3.42%10.31%12.11%6.13%19.54%
EPS (Basic)
-0.00-0.03-0.01-0.02-0.06
EPS (Diluted)
-0.00-0.03-0.01-0.02-0.06
EPS Growth
-----

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-0.16-0.77-3.29-6.03-13.06
Free Cash Flow Per Share
--0.00-0.01-0.02-0.04
EBITDA
-1.07-1.65-3.29-5.52-17.84
D&A For EBITDA
00000
EBIT
-1.07-1.65-3.29-5.53-17.84